Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2026-01-06 @ 3:10 AM
Study NCT ID:
NCT00468169
Status:
COMPLETED
Last Update Posted:
2019-10-09
First Post:
2007-04-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer
Sponsor:
University of Chicago
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-07
Start Date Type:
None
Primary Completion Date:
2012-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-11
Completion Date Type:
ACTUAL
First Submit Date:
2007-04-30
First Submit QC Date:
None
Study First Post Date:
2007-05-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-08-12
Results First Submit QC Date:
None
Results First Post Date:
2019-10-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-20
Last Update Post Date:
2019-10-09
Last Update Post Date Type:
ACTUAL